TrialBMJ open diabetes research & care2023

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial.

Marina Shestakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.